Exec-Edge – Page 30 – ExecEdge

Lisata Therapeutics Partners with Catalent on ADC Technology

Lisata Therapeutics Partners with Catalent on ADC Technology

By Karen Roman Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it started a global product license agreement with Catalent, Inc., enabling the latter to include Lisata’s certepetide into antibody-drug conjugates (ADCs) developed using Catalent’s SMARTag technology platform. The partnership is a...

Input your search keywords and press Enter.